245057-73-2

Basic information

• Product Name: 4-(3,4-DICHLOROPHENOXY)PIPERIDINE
• Synonyms: 4-(3,4-DICHLOROPHENOXY)PIPERIDINE;Piperidine, 4-(3,4-dichlorophenoxy)-
• CAS NO: 245057-73-2
• Molecular Formula: C₁₁H₁₃Cl₂NO
• Molecular Weight: 246.13
• Mol File: 245057-73-2.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 346.3±42.0 °C(Predicted)
• Appearance: /
• Density: 1.256±0.06 g/cm3(Predicted)
• PKA: 9.59±0.10(Predicted)
• CAS DataBase Reference: 4-(3,4-DICHLOROPHENOXY)PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3,4-DICHLOROPHENOXY)PIPERIDINE(245057-73-2)
• EPA Substance Registry System: 4-(3,4-DICHLOROPHENOXY)PIPERIDINE(245057-73-2)

Safety Data

• Hazardous Substances Data: 245057-73-2(Hazardous Substances Data)

Usage

General Description

4-(3,4-dichlorophenoxy)piperidine is a chemical compound with the molecular formula C11H14Cl2NO. It is a piperidine derivative that contains two chlorine atoms and a 3,4-dichlorophenoxy group. This chemical has various applications in the field of chemistry and pharmaceuticals. It is known to exhibit activity as a dopamine receptor agonist, and its derivatives have been investigated for potential use in the treatment of neurological disorders such as Parkinson's disease. Additionally, this compound has also been studied for its potential use as an insecticide due to its ability to disrupt the nervous system of pests. Overall, 4-(3,4-dichlorophenoxy)piperidine is an important chemical that has potential applications in the fields of medicine and agriculture.

Upstream product

• 260441-48-3 tert-Butyl 4-(3,4-dichlorophenoxy)-1-piperidinecarboxylate 
• 95-77-2 3,4-dichlorophenol 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 1435-49-0 3,4-dichlorofluorobenzene 

Downstream Products

• 676517-41-2 1,1-dimethylethyl 4-[[4-(3,4-dichlorophenoxy)-1-piperidinyl]methyl]-1-piperidinecarboxylate 
• 377741-15-6 2-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-N-[4-(methylsulfonyl)phenyl]ethanesulfonamide 
• 356557-75-0 N-{2-[(3-{4-[(3,4-Dichlorophenyl)oxy]-1-piperidinyl}-2-hydroxy-2-methylpropyl)oxy]-4-fluorophenyl)acetamide hydrochloride 
• 1413286-14-2 C₂₄H₂₆Cl₂N₆O₂ 
• 1413286-15-3 C₂₇H₃₂Cl₂N₂O₆S 
• 1413286-16-4 C₂₆H₃₁Cl₂N₃O₄ 
• 1413286-17-5 C₂₉H₃₄Cl₂N₆O₄ 
• 367500-74-1 4-(3,4-dichloro-phenoxy)-[1,4']bipiperidine 
• 367497-18-5 C₂₅H₂₈Cl₂N₂O₅ 
• 1413286-11-9 C₂₄H₂₆Cl₂N₂O₄ 
• 1413286-12-0 C₂₄H₂₆Cl₂N₂O₄ 
• 1413286-13-1 C₂₅H₂₆Cl₂N₄O₄ 
• 485391-81-9 C₂₃H₂₇Cl₂N₃O₄S 
• 583881-11-2 C₂₂H₂₆Cl₂N₂O₅S 

Relevant articles and documents

AZETIDINE AND SPIROAZETIDINE COMPOUNDS AND USES THEREOF

The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.

MMP INHIBITORS AND METHODS OF USE THEREOF

Provided are MMP inhibitors having the Formula (I): wherein R1, R2 and Y are as defined herein, which are useful in the treatment and/or prevention of MMP-mediated diseases and disorders.

Chemical compounds

The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.